The Ministry of Health and Long-Term Care (MOHLTC) has announced it has expanded the list of drugs that optometrists may prescribe for the treatment of eye and vision conditions. As of February 6, 2017, an additional 11 drugs have been included in the list of drugs controlled by Ontario’s Designated Drugs Regulation. Optometrists should familiarize themselves with the new drugs and prescribe them only in line with the standards of practice set out in the regulation and in OPR 4.4 (updated version coming soon). Optometrists are expected to understand the benefits and risks, including contraindications, of any drug prior to prescribing.
